We are thrilled to receive the 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan. The award is part of the Frost & Sullivan Best Practices Award series, which recognizes companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development.

We are pleased that Frost & Sullivan recognizes the enabling platform WuXi has been diligently building over the years. It’s an honor to serve our innovative partners around the world and help expedite the discovery and development of better medicines for patients.

Official Press Release